The Association of an Alpha2C Adrenoreceptor Gene Polymorphism with Vasomotor Symptoms in African American Women

Overview

Journal Menopause

Specialty Gynecology & Obstetrics

Date 2018 Oct 3

PMID 30277919

Authors

Devora A Aharon

Elissa Gretz Friedman

Jessica R Overbey

Maryann McLaughlin

Taimour Langaee

Rebecca C Thurston

Affiliations

Soon will be listed here.

Abstract

Objective: The alpha2C adrenoreceptor deletion 322-325 (ADRA2C del 322-325) polymorphism has been associated with autonomic activity and thermoregulation, which are implicated in the vasomotor symptom (VMS) mechanism. The ADRA2C del (322-325) has higher prevalence in African American women, a group known to experience more frequent and bothersome VMS. We assessed whether the ADRA2C del (322-325) genotype is associated with increased frequency of VMS in African American women.

Methods: DNA samples from African American (N = 400) women participating in the Study of Women's Health Across the Nation (SWAN) were genotyped for the ADRA2C del (322-325) polymorphism. Longitudinal data on VMS were obtained from the SWAN repository. The relation of ADRA2C del (322-325) genotypes (deletion/deletion [D/D]; insertion/deletion [I/D]; insertion/insertion [I/I]) with VMS over the menopausal transition for up to 12 years of follow-up was examined using generalized estimating equations. Primary models considered the outcome of frequent VMS (6 or more days in the prior 2 wk vs VMS <6 d in the prior 2 wk) by stage of menopause.

Results: Four hundred DNA samples from African American women were included. Seventy-five women (18.8%) were found to carry the homozygous variant allele (D/D). There was no significant difference in the trajectory of frequent VMS over the menopausal transition between women with D/D and I/I + I/D genotypes (P = 0.39).

Conclusions: In this preliminary study among African American women in SWAN, ADRA2C del (322-325) was not significantly related to self-reported VMS. Further studies are warranted to help us understand the role of the adrenergic system in the physiology of VMS to tailor medical therapy to patient needs.

References

Small K, Wagoner L, Levin A, Kardia S, Liggett S . Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002; 347(15):1135-42. DOI: 10.1056/NEJMoa020803. View

Small K, Forbes S, Rahman F, Bridges K, Liggett S . A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 2000; 275(30):23059-64. DOI: 10.1074/jbc.M000796200. View

Thurston R, Christie I, Matthews K . Hot flashes and cardiac vagal control: a link to cardiovascular risk?. Menopause. 2010; 17(3):456-61. PMC: 2866826. DOI: 10.1097/gme.0b013e3181c7dea7. View

Link R, Stevens M, Kulatunga M, Scheinin M, Barsh G, Kobilka B . Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog. Mol Pharmacol. 1995; 48(1):48-55. View

Kardia S, Chu J, Sowers M . Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN). Am J Med. 2006; 119(9 Suppl 1):S3-15. DOI: 10.1016/j.amjmed.2006.07.001. View

Thurston R, Christie I, Matthews K . Hot flashes and cardiac vagal control during women's daily lives. Menopause. 2011; 19(4):406-12. PMC: 3292670. DOI: 10.1097/gme.0b013e3182337166. View

Crandall C, Crawford S, Gold E . Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med. 2006; 119(9 Suppl 1):S52-60. DOI: 10.1016/j.amjmed.2006.07.007. View

Filipeanu C . Temperature-Sensitive Intracellular Traffic of α2C-Adrenergic Receptor. Prog Mol Biol Transl Sci. 2015; 132:245-65. DOI: 10.1016/bs.pmbts.2015.02.008. View

Thurston R, Bromberger J, Joffe H, Avis N, Hess R, Crandall C . Beyond frequency: who is most bothered by vasomotor symptoms?. Menopause. 2008; 15(5):841-7. PMC: 2866103. DOI: 10.1097/gme.0b013e318168f09b. View

10.

Neumeister A, Drevets W, Belfer I, Luckenbaugh D, Henry S, Bonne O . Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology. 2006; 31(8):1750-6. DOI: 10.1038/sj.npp.1301010. View

11.

Freedman R . Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril. 1998; 70(2):332-7. DOI: 10.1016/s0015-0282(98)00137-x. View

12.

Freedman R, Kruger M, Wasson S . Heart rate variability in menopausal hot flashes during sleep. Menopause. 2011; 18(8):897-900. PMC: 3181047. DOI: 10.1097/gme.0b013e31820ac941. View

13.

Scheinin M, Lomasney J, Hayden-Hixson D, Schambra U, Caron M, Lefkowitz R . Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res. 1994; 21(1-2):133-49. DOI: 10.1016/0169-328x(94)90386-7. View

14.

Harlow S, Karvonen-Gutierrez C, Elliott M, Bondarenko I, Avis N, Bromberger J . It is not just menopause: symptom clustering in the Study of Women's Health Across the Nation. Womens Midlife Health. 2018; 3. PMC: 5760187. DOI: 10.1186/s40695-017-0021-y. View

15.

Nicholas A, Pieribone V, Hokfelt T . Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol. 1993; 328(4):575-94. DOI: 10.1002/cne.903280409. View

16.

Jnoff E, Christophe B, Collart P, Coloretti F, Debeuckelaere A, de Ryck M . Discovery of selective alpha(2C) adrenergic receptor agonists. ChemMedChem. 2012; 7(3):385-90. DOI: 10.1002/cmdc.201100528. View

17.

Gold E, Colvin A, Avis N, Bromberger J, Greendale G, Powell L . Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health. 2006; 96(7):1226-35. PMC: 1483882. DOI: 10.2105/AJPH.2005.066936. View

18.

Regard J, Sato I, Coughlin S . Anatomical profiling of G protein-coupled receptor expression. Cell. 2008; 135(3):561-71. PMC: 2590943. DOI: 10.1016/j.cell.2008.08.040. View

19.

Freedman R, Krell W . Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999; 181(1):66-70. DOI: 10.1016/s0002-9378(99)70437-0. View

20.

Kohli U, Muszkat M, Sofowora G, Harris P, Friedman E, Dupont W . Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain. 2009; 14(2):154-9. PMC: 2815116. DOI: 10.1016/j.ejpain.2009.04.003. View